ACHE and myasthenia gravis: In addition, MuSK-MG patients can present with adverse effects when treated with pyridostigmine, an AChE inhibitor commonly used as a first-line treatment for MG, while there is little evidence to support the usefulness of thymectomy in these patients (130).